Summary
This prediction ended on 23.08.23 with a price of €1.25. With a performance of -5.03%, the BUY prediction by krebskrebs finished with a loss. Dividends of €0.60 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Speqta AB | -3.333% | -3.333% | -62.615% | -98.408% |
| iShares Core DAX® | -0,37 % | 8,40 % | 6,76 % | 47,91 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % | 36,18 % | 94,08 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % | 43,11 % | 64,80 % |
| iShares S&P 500 | 1,22 % | 10,49 % | 27,28 % | 66,76 % |
Comments by krebskrebs for this prediction
In the thread Speqta AB diskutieren
In the thread Trading Speqta AB
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten